StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Intangible Assets Other than Goodwill by Year

Intangible Assets Other than Goodwill (Quarterly & Annual) ($M)

Novartis Intangible Assets Other than Goodwill: $29,411M in FY2025, up 9.3% from a year earlier.

Latest, FY2025
29,411
Period ended Dec 31, 2025
Change on a year earlier
+9.3%
26,915 in FY2024
History
9 years
Since FY2017
Sources
9
Documents cited below

Where the FY2025 figure comes from

“|| Intangible assets other than goodwill | 39 827 | 29 411”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F Note 10.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedIntangible Assets Other than Goodwill (Quarterly & Annual) ($M)Year on yearSource
FY2025Dec 31, 202529,411+9.3%Novartis Form 6-K (0001114448-26-000014) ↗
FY2024Dec 31, 202426,915+0.1%Novartis Form 6-K (0001114448-25-000003) ↗
FY2023Dec 31, 202326,879-15.1%Novartis Form 6-K (0001370368-24-000022) ↗
FY2022Dec 31, 202231,644-7.4%Novartis Form 6-K (0001370368-23-000068) ↗
FY2021Dec 31, 202134,182-7.1%Novartis Form 6-K (0001370368-22-000077) ↗
FY2020Dec 31, 202036,809+27.9%Novartis Form 6-K (0001370368-21-000072) ↗
FY2019Dec 31, 201928,787-25.7%Novartis Form 6-K (0001370368-20-000086) ↗
FY2018Dec 31, 201838,719+29.1%Novartis Form 6-K (0001370368-19-000062) ↗
FY2017Dec 31, 201729,997–Novartis Form 20-F (0001370368-19-000002) ↗

Breakdown

What makes up intangible Assets Other than Goodwill

Cite this data

StockData. (2026). Novartis Intangible Assets Other than Goodwill ($M), annual FY2017–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/ops-intangibles-ex-goodwill

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.